Robotic Catheter Could Improve Treatment of Heart Condition

Key points
- Atrial fibrillation is a heart disorder that affects more than two million Americans, and is considered a key contributor to blood clots and stroke.
- “We are developing a robotic catheter with significantly improved maneuverability and control,” says Dr.
- Atrial fibrillation occurs when there is random electrical activity in the upper chambers of the heart, the atria.
- Doctors have developed a cardiac ablation technique that mitigates fibrillation by inserting a catheter into the heart and then using extreme heat or cold to create small scars through the walls of the affected atria.
Atrial fibrillation is a heart disorder that affects more than two million Americans, and is considered a key contributor to blood clots and stroke. Now researchers from North Carolina State University are developing a new computerized catheter that could make the surgical treatment of atrial fibrillation faster, cheaper and more effective – while significantly decreasing radiation exposure related to the treatment.
“We are developing a robotic catheter with significantly improved maneuverability and control,” says Dr. Gregory Buckner, a professor of mechanical and aerospace engineering at NC State and lead researcher of the team developing the new catheter. “This should reduce the time needed to perform atrial ablation procedures and improve patient outcomes.”
Atrial fibrillation occurs when there is random electrical activity in the upper chambers of the heart, the atria. This causes the heart to operate less efficiently, and can lead to lightheadedness and fatigue. It can also lead to blood pooling in the heart, which contributes to blood clots and increased risk of stroke.
Doctors have developed a cardiac ablation technique that mitigates fibrillation by inserting a catheter into the heart and then using extreme heat or cold to create small scars through the walls of the affected atria. These scars block the problematic electrical signals. Throughout this procedure, doctors use X-rays to track the tip of the catheter – exposing the patient and medical personnel to radiation.
Existing commercial catheters are manually controlled and can only move in two directions. These catheters require doctors to painstakingly manipulate the catheter to control exactly where each individual lesion should be applied.
But the robotic catheter developed by Buckner’s team significantly reduce operating times, utilizing “smart materials” to provide significantly better maneuverability. The smart materials act as internal muscles, contracting when an electric current is applied. This allows the catheter to bend left, right, up, down or any combination of those directions. Furthermore, doctors can use a specialized joystick to locate key points on the atrium. A computer program can then trace a curve along those points – essentially connecting the dots – creating a solid line of scar tissue that will block the electric signals causing fibrillation.
“If we can reduce the duration of the procedure, it will simultaneously reduce radiation exposure for the patient and medical personnel,” Buckner says. “It will also provide cost savings for hospitals and health insurance companies.”
The researchers received a Phase II Small Business Innovation Research grant from the National Institutes of Health in August to take their “robotic catheter” prototype from the lab and put it into the hands of doctors. The $1.1 million grant will fund two years of development and surgical testing. Approximately half of these funds will go to NC State, while the remainder will go to Southeast TechInventures, which will help bring the technology to the marketplace.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsHot Topics in Heart Disease Prevention and Treatment
From prevention to treatment, cardiovascular medicine is changing rapidly. During Heart Disease Awareness Month, experts at the University of Michigan Cardiovascular Center are available to discuss new strategies for…
17 February 2012
NewsWarfarin and aspirin are similar in heart failure treatment
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to…
6 February 2012
NewsNiacin Does Not Reduce Heart Attack, Stroke Risk in Stable, Cardiovascular Patients Whose Cholesterol is Well-Controlled to Treatment Guidelines
In patients whose bad cholesterol is very well-controlled by statins for a long time period, the addition of high-dose, extended release niacin did not reduce the risk of cardiovascular events, including heart attack…





